RG

Rupa Gupta

Active Director Director DIN 03602896
DIN 03602896 First appointment Aug 2011 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2011
Shareholding value •••• Premium profile

About Rupa Gupta

Data last updated:

Rupa Gupta is a Director at Dicore Pharmaceuticals Private Limited (since 2011). The company operates in Trading. Dicore Pharmaceuticals Private Limited reported revenue of ₹8.3 Lakh (FY 2024).

DIN 03602896
Primary Designation Director
Industry Trading
First Appointment 30 Aug 2011
Oldest Company Age 15 yrs
Largest company Dicore Pharmaceuticals Private Limited · ₹8.3 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Aug 20112011₹8.3 Lakh (FY 2024)Active

Board colleagues of Rupa Gupta

NameDINCompanyDesignation
Sanjeev Gupta03602898Dicore Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Dicore Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rupa Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rupa Gupta

Rupa Gupta currently holds 1 directorship: Dicore Pharmaceuticals Private Limited (Director, since 30 Aug 2011, revenue ₹8.3 Lakh (FY 2024)).

Rupa Gupta was first appointed on 30 Aug 2011 as Director at Dicore Pharmaceuticals Private Limited.

The current boards of Rupa Gupta's companies include Sanjeev Gupta (Dicore Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available